New regulatory playbook to guide AAV gene therapy development for rare diseases
Feb. 7, 2024
The Foundation for the National Institutes of Health (FNIH) has announced the online publication of the first playbook designed to help accelerate the development of adeno-associated virus (AAV) gene therapies for rare diseases.